Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Kwality Pharmaceuticals Ltd Performance

Today's Low
490.00
arrowIcon
Today's High
505.00
52 Wk Low
248.00
arrowIcon
52 Wk High
545.00


Open

505

Traded Value (Cr)

37.77 L

Prev. Close

495.4

VWAP

495.77

Volume

7,662

Face Value

10

Kwality Pharmaceuticals Ltd Fundamentals

Market Cap
₹ 514 Cr
P/E Ratio (TTM)
18.14
P/B Ratio
2.43
Debt to Equity
0.43
ROE
13.08 %
EPS (TTM)
27.31
Dividend Yield
0.00%
Book Value
203.60

Click here to know more about Fundamentals

Kwality Pharmaceuticals Ltd Financials

Kwality Pharmaceuticals Ltd Financials

Kwality Pharmaceuticals Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 54.83 % 54.77 % 54.77 % 54.74 %
Retail 31.71 % 32.95 % 31.64 % 29.29 %
Others 13.47 % 12.28 % 13.59 % 15.97 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

54.83%

Retail

31.71%

Others

13.47%

FII

0.00%

Mutual Funds

0.00%

Promoters

54.77%

Retail

32.95%

Others

12.28%

FII

0.00%

Mutual Funds

0.00%

Promoters

54.77%

Retail

31.64%

Others

13.59%

FII

0.00%

Mutual Funds

0.00%

Promoters

54.74%

Retail

29.29%

Others

15.97%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹496.48

PIVOT

resistance-arrow
Resistance
First Resistance₹508.917
Second Resistance₹515.433
Third Resistance₹527.867
support-arrow
Support
First Resistance₹489.967
Second Resistance₹477.533
Third Resistance₹471.017
RSI69.007
MACD19.028
ADX30.912
CCI37.384

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day7,3746,30385.48
Week7,5756,23884.58
1 Month8,4657,31389.98
6 Months000.00

About Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics. With little background of finished pharmaceuticals and high held spirits and will, he started this business. He received his first drug license in 1981 approved for liquid oral manufacturing. Presently, the Company has 48 different sections available at their production centres. Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables. The Company has the most modern & sophisticated Plant, Equipment, technique, and workforce. Certified as ISO: 9001:2015 and ISO 14001:2015, it is working with new SCHEDULE M and WHO norms and certified with GMP. The Company is keeping all records of inputs used in manufacturing. The inputs are tested as per standard laid down by company SOP. The in-process testing records are also maintained as per SOP. Similarly, finished goods are also tested as per SOP and are then allowed for sale. Apart from these, the Company is making medicines in various dosage forms like Liquid Orals, Powder for Oral Suspension, Tablets, Capsules, Dry Syrup, Syrup, Sterile Powder for Injections, small volume injectables, Ointments, External Preparations, ORS and many more in various categories like Beta Lactam & non-Beta Lactam, Hormones, Cytotoxic (Oncology) and Effervescent as per new GMP norms. Besides, it manufacture the latest drugs for the management of viral infections/diseases in different dosage forms. Each category of product is processed in a separate section, which is equipped with the latest machinery. All sections are supported by a centralized quality control department which has different segments. Each segment is equipped with the latest scientific machinery, ingredients, and trained staff supported by SOP. These segments are instrumental testing, chemical testing, pyrogen testing, and Bacterial endotoxin testing and microbiology, etc. The Company had put up a multi-storied factory building in Nag Kalan, Amritsar, which started its production in March 2006. The new factory was as per WHO GMP norms. It put up the Jassur Plant in Himachal Pradesh. This unit was in the TAX-free zone, which has helped the Company to sell its Products into the Indian retail market. Kwality Pharmaceuticals, as an exporting company has supplied Remdesivir Injection to the global market and similarly Propofol injection was short in supply in various high profile countries who normally accept US FDA companies' products. But in shortage of medicine, they procured these injections from the Company and after seeing the performance and efficacy, they registered the product. They started procuring the other items of the Company and it became world recognized and now the booking grew which has yielded more sales and profit for the Company.

Managing Director

Ramesh Arora

Founded

1983

NSE Symbol

Kwality Pharmaceuticals Ltd Management

NameDesignation
Ramesh AroraManaging Director
Ajay AroraWhole-time Director
Ravi Shanker SinghIndependent Director
Geeta AroraWhole-time Director
Anju AroraWhole-time Director
Aditya AroraWhole Time Director & CFO
Pankaj TakkarIndependent Director
Kiran Kumar VermaIndependent Director
Gurpreet KaurCompany Sec. & Compli. Officer
Kartik KapurIndependent Director
Sachin SethDirector

Kwality Pharmaceuticals Ltd News

Kwality Pharmaceuticals to table results
On 23 May 2024
Kwality Pharmaceuticals consolidated net profit rises 8.31% in the December 2023 quarter
Sales rise 38.97% to Rs 78.10 crore
Kwality Pharmaceuticals to declare Quarterly Result
On 6 February 2024
Kwality Pharmaceuticals consolidated net profit declines 33.76% in the September 2023 quarter
Sales rise 24.80% to Rs 69.65 crore
Kwality Pharmaceuticals standalone net profit declines 30.83% in the September 2023 quarter
Sales rise 24.46% to Rs 69.65 crore
Kwality Pharmaceuticals to hold board meeting
On 4 November 2023
Kwality Pharmaceuticals Ltd leads losers in 'B' group
Creative Eye Ltd, Parshva Enterprises Ltd, Baid Finserv Ltd and Steel Exchange India Ltd are among the other losers in the BSE's 'B' group today, 06 October 2023.
Kwality Pharmaceuticals to conduct AGM
On 30 September 2023
Kwality Pharmaceuticals consolidated net profit declines 48.58% in the June 2023 quarter
Sales decline 3.94% to Rs 67.45 crore
Kwality Pharmaceuticals standalone net profit declines 48.34% in the June 2023 quarter
Sales decline 3.94% to Rs 67.45 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,304 Cr
₹ 1,493.35
(-1.85 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,358.80
(-1.88 %)
33.36
DIVISLAB₹ 1,00,599 Cr
₹ 3,789.50
(-3.55 %)
73.75
DRREDDY₹ 98,073 Cr
₹ 5,879.05
(-2.93 %)
22.59
ZYDUSLIFE₹ 97,383 Cr
₹ 967.80
(-3.77 %)
36.23

Kwality Pharmaceuticals Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Kwality Pharmaceuticals Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Kwality Pharmaceuticals Ltd's share price is ₹492.90 as of May 9, 2024

Kwality Pharmaceuticals Ltd's P/E ratio is 18.14 times as of May 9, 2024.

Kwality Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 2.43, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Kwality Pharmaceuticals Ltd's market is 514 Cr as on May 9, 2024.

The current financial records of Kwality Pharmaceuticals Ltd show a 13.08% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Kwality Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Kwality Pharmaceuticals Ltd's 52-week high and low as of May 9, 2024 are ₹505 and ₹490 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Kwality Pharmaceuticals Ltd stands at 54.83%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.